CD16-II variants
US6444789B1 · kind B1 · utility
59Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 3, 1995 |
| Grant date | Sep 3, 2002 |
| Priority date | — |
| Expiry date | May 3, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human CD16-II variants, DNA sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses, as well as pharmaceutical compositions comprising them, are disclosed. The sequence listing for the new polypeptides is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.